Supplementary Table S1 displays the patients’ information. We found that HCC tumors exhibiting higher GALNT1 expression levels are associated with poorer patient overall five-year survival (Figure 1D), p < 0.05. These findings show that GALNT1 is often overexpressed in HCC tumors and that higher GALNT1 expression level is correlated with decreased HCC patient overall survival. Here, GALNT1 is linked to hepatocellular carcinoma.